Kjemoradioterapi

Kjemoradioterapi is a cancer treatment that combines chemotherapy and radiation therapy. This approach is used for certain types of cancer, often when the cancer is advanced or has a higher risk of spreading. The goal of kjemoradioterapi is to enhance the effectiveness of both treatments. Chemotherapy drugs work by killing rapidly dividing cells, including cancer cells, throughout the body. Radiation therapy, on the other hand, uses high-energy rays to target and destroy cancer cells in a specific area.

When used together, chemotherapy can make cancer cells more sensitive to radiation, meaning the radiation therapy can kill more cancer cells. Conversely, radiation therapy can help to shrink tumors, potentially making them more susceptible to chemotherapy. Kjemoradioterapi is typically administered over a period of several weeks, with chemotherapy drugs given either before, during, or after radiation sessions. The specific drugs used and the radiation dosage are tailored to the type and stage of cancer, as well as the patient's overall health. Side effects can occur from both treatments and may include fatigue, nausea, skin irritation in the treated area, and effects on blood cell counts. The decision to use kjemoradioterapi is made by a medical oncologist and radiation oncologist after careful consideration of the potential benefits and risks for the individual patient.